These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 15564492)
1. Long-term excretion of vaccine-derived poliovirus by a healthy child. Martín J; Odoom K; Tuite G; Dunn G; Hopewell N; Cooper G; Fitzharris C; Butler K; Hall WW; Minor PD J Virol; 2004 Dec; 78(24):13839-47. PubMed ID: 15564492 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa. Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568 [TBL] [Abstract][Full Text] [Related]
3. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria. Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545 [TBL] [Abstract][Full Text] [Related]
4. Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child. Adu F; Iber J; Bukbuk D; Gumede N; Yang SJ; Jorba J; Campagnoli R; Sule WF; Yang CF; Burns C; Pallansch M; Harry T; Kew O Virus Res; 2007 Jul; 127(1):17-25. PubMed ID: 17449127 [TBL] [Abstract][Full Text] [Related]
5. Characterization of a rare natural intertypic type 2/type 3 penta-recombinant vaccine-derived poliovirus isolated from a child with acute flaccid paralysis. Zhang Y; Wang H; Zhu S; Li Y; Song L; Liu Y; Liu G; Nishimura Y; Chen L; Yan D; Wang D; An H; Shimizu H; Xu A; Xu W J Gen Virol; 2010 Feb; 91(Pt 2):421-9. PubMed ID: 19846676 [TBL] [Abstract][Full Text] [Related]
6. Changes in population dynamics during long-term evolution of sabin type 1 poliovirus in an immunodeficient patient. Odoom JK; Yunus Z; Dunn G; Minor PD; Martín J J Virol; 2008 Sep; 82(18):9179-90. PubMed ID: 18596089 [TBL] [Abstract][Full Text] [Related]
7. Circulation of a type 1 recombinant vaccine-derived poliovirus strain in a limited area in Romania. Combiescu M; Guillot S; Persu A; Baicus A; Pitigoi D; Balanant J; Oprisan G; Crainic R; Delpeyroux F; Aubert-Combiescu A Arch Virol; 2007; 152(4):727-38. PubMed ID: 17195957 [TBL] [Abstract][Full Text] [Related]
12. Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient. Yang CF; Chen HY; Jorba J; Sun HC; Yang SJ; Lee HC; Huang YC; Lin TY; Chen PJ; Shimizu H; Nishimura Y; Utama A; Pallansch M; Miyamura T; Kew O; Yang JY J Virol; 2005 Oct; 79(20):12623-34. PubMed ID: 16188964 [TBL] [Abstract][Full Text] [Related]
13. Vaccine-derived poliovirus from long term excretors and the end game of polio eradication. Martín J Biologicals; 2006 Jun; 34(2):117-22. PubMed ID: 16650772 [TBL] [Abstract][Full Text] [Related]
14. [Analysis on identification and genetic character of type I vaccine-derived poliovirus in Shanxi province in 2007]. Yan DM; Zhu SL; Zhang Y Zhongguo Yi Miao He Mian Yi; 2009 Apr; 15(2):131-4. PubMed ID: 20077658 [TBL] [Abstract][Full Text] [Related]
15. Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia. Shahmahmoodi S; Parvaneh N; Burns C; Asghar H; Mamishi S; Tabatabaie H; Chen Q; Teimourian S; Gooya MM; Esteghamati AR; Mousavi T; Yousefi M; Farrokhi K; Mashlool M; Kew O; Nategh R Virus Res; 2008 Oct; 137(1):168-72. PubMed ID: 18674576 [TBL] [Abstract][Full Text] [Related]
16. Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1. Blomqvist S; Bruu AL; Stenvik M; Hovi T J Gen Virol; 2003 Mar; 84(Pt 3):573-580. PubMed ID: 12604808 [TBL] [Abstract][Full Text] [Related]
17. Oral poliovaccine: will it help eradicate polio or cause the next epidemic? Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227 [TBL] [Abstract][Full Text] [Related]
18. Determinants of monovalent oral polio vaccine mutagenesis in vaccinated elderly people. Boot HJ; Sonsma J; van Nunen F; Abbink F; Kimman TG; Buisman AM Vaccine; 2007 Jun; 25(24):4706-14. PubMed ID: 17482726 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of vaccine-derived polioviruses in sewage and river water in South Africa. Pavlov DN; Van Zyl WB; Van Heerden J; Grabow WO; Ehlers MM Water Res; 2005 Sep; 39(14):3309-19. PubMed ID: 15996707 [TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of poliovirus isolates from children who contracted vaccine-associated paralytic poliomyelitis (VAPP) following administration of monovalent type 3 oral poliovirus vaccine in the 1960s in Hungary. Kapusinszky B; Molnár Z; Szomor KN; Berencsi G FEMS Immunol Med Microbiol; 2010 Mar; 58(2):211-7. PubMed ID: 19863665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]